Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
RenovoRx, Inc. issued 5,319,392 shares of Common Stock of warrant to 15 accredited investors or qualified institutional buyers for exercise price equal to $1.751 per share for the Institutional Investors and $1.9326 for the Insiders.
- Security
- warrant
- Shares
- 5,319,392 shares of Common Stock
- Purchaser
- 15 accredited investors or qualified institutional buyers
- Consideration
- exercise price equal to $1.751 per share for the Institutional Investors and $1.9326 for the Insiders
Exact text from the filing
product sales) for any calendar quarter in a quarterly or annual report. The Milestone Warrants will entitle the holder to purchase Warrant Shares at an exercise price equal to $1.751 per share for the Institutional Investors and $1.9326 for the Insiders. The Milestone Warrants are subject to a beneficial ownership limitation, preventing any holder from
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
RenovoRx, Inc. issued 2,200,000 shares of Common Stock of warrant to 15 accredited investors or qualified institutional buyers for price per share of Common Stock being sold to the Institutional Investors in the Offering, minus $0.0001.
- Security
- warrant
- Shares
- 2,200,000 shares of Common Stock
- Purchaser
- 15 accredited investors or qualified institutional buyers
- Consideration
- price per share of Common Stock being sold to the Institutional Investors in the Offering, minus $0.0001
Exact text from the filing
Securities Purchase Agreement, in connection with the Offering, the Company sold to the Investors an aggregate of: (i) 8,438,790 shares (the “Shares”) of common stock, par value $0.0001 per share, of the Company (the “Common Stock”), (ii) pre-funded warrants to purchase an aggregate of 2,200,000 shares of Common Stock (the “Pre-Funded Warrants”) and (iii)
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
RenovoRx, Inc. issued 8,438,790 shares of common stock to 15 accredited investors or qualified institutional buyers for $0.938 per Share.
- Security
- common stock
- Shares
- 8,438,790 shares
- Purchaser
- 15 accredited investors or qualified institutional buyers
- Consideration
- $0.938 per Share
Exact text from the filing
and Milestone Warrants are referred to herein as the “Warrant Shares.” The purchase price paid by the Institutional Investors for each Share and related Milestone Warrant was $0.938. To comply with Nasdaq Stock Market rules, the purchase price paid by the Insiders for each Share and related Milestone Warrant was $1.0288. The Securities Purchase Agreement
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
RenovoRx, Inc. entered into Securities Purchase Agreement with 15 accredited investors or qualified institutional buyers valued at aggregate gross proceeds of approximately $10 million (effective 2026-03-17).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- 15 accredited investors or qualified institutional buyers
- Value
- aggregate gross proceeds of approximately $10 million
- Effective
- 2026-03-17
Exact text from the filing
On March 17, 2026, RenovoRx, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agreement (the “Securities Purchase Agreement”) in connection with a private placement offering by the Company (the “Offering”) to 15 accredited investors or qualified institutional buyers (the “Investors”), five of whom are directors, officers or employees of the Company (the “Insiders”) and the remaining are non-affiliated institutional investors (the “Institutional Investors”).
View on SEC.gov